{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "N.D. (Transcript and position not specified in the text)",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "LRRK2 mutations (G2019S, R1941H, I2012T, I2020T, G2385R, R1441C, R1441G, Y1699C, T2356I) associated with Parkinson's disease"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005311"
  },
  "Experiment Method": [
    {
      "Assay Method": "KESTREL screen (phosphorylation analysis of proteins by LRRK2 mutants)",
      "Material used": {
        "Material Source": "Rat brain extracts",
        "Material Name": "N.D.",
        "Description": "Rat brain extracts were used to identify phosphorylated proteins by LRRK2 mutants."
      },
      "Readout type": "Qualitative/Quantitative",
      "Readout description": [
        {
          "Variant": "N.D. (Transcript and position not specified in the text)",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function (G2019S) or loss-of-function (others)",
          "Result Description": "G2019S stimulated kinase activity, while R1941H, I2012T, I2020T, G2385R inhibited it; R1441C, R1441G, Y1699C, T2356I had no effect. Phosphorylation of moesin, ezrin, radixin, and a peptide was observed."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}